structure_rank,hugo_name,uniprot_id,uniprot_isoform,structure_id,deposition_date,experimental_method,resolution,complex_protein,complex_protein_details,complex_nucleotide,complex_nucleotide_details,complex_ligand,complex_ligand_details,chains,coverage,mutations_in_pdb,warnings
0,BCL2,P10415,1,AF-P10415-F1-model_v4,2022-06-01,Predicted,NA,NA,NA,NA,NA,NA,NA,A,"[(8, 32);(86, 114);(116, 203)]",NA,NA
1,BCL2,P10415,1,6GL8,2018-05-23,X-RAY DIFFRACTION,1.4,fusion product,"['BCL2_HUMAN, P10415, chain_A;B2CL1_HUMAN, Q07817, chain_A']",NA,NA,Other ligands,"['~{N}-(4-hydroxyphenyl)-3-[6-[[(3~{S})-3-(morpholin-4-ylmethyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]-1,3-benzodioxol-5-yl]-~{N}-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide, chain A']",A,"[(7, 35);(48, 50);(92, 203)]","['T7G', 'G8S', 'D34A', 'V35D', 'I48E', 'F49S', 'S50E', 'L95K', 'Q99E']","The structure likely contains an expression tag,"
2,BCL2,P10415,1,6O0K,2019-02-16,X-RAY DIFFRACTION,1.62,fusion product,"['BCL2_HUMAN, P10415, chain_A;B2CL1_HUMAN, Q07817, chain_A']",NA,NA,Other ligands,"4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-[(3-nitro-4-{[(oxan-4-yl)methyl]amino}phenyl)sulfonyl]-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide, chain A;NONAETHYLENE GLYCOL, chain A",A,"[(9, 35);(90, 203)]","['V35D', 'P90S', 'P91E']",NA
3,BCL2,P10415,1,6O0M,2019-02-16,X-RAY DIFFRACTION,1.75,fusion product,"['BCL2_HUMAN, P10415, chain_A;B2CL1_HUMAN, Q07817, chain_A']",NA,NA,Other ligands,"4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-[(3-nitro-4-{[(oxan-4-yl)methyl]amino}phenyl)sulfonyl]-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide, chain A;DI(HYDROXYETHYL)ETHER, chain A",A,"[(8, 34);(90, 203)]","['P90S', 'P91E', 'F104L']",NA
4,BCL2,P10415,1,5VAU,2017-03-28,X-RAY DIFFRACTION,1.754,protein complex,"['BECN1_HUMAN, Q14457, chain_E;BCL2_HUMAN, P10415, chain_A']",NA,NA,NA,NA,B;A;D;C,"[(10, 31);(89, 203)];[(1, 32);(90, 206)];[(10, 32);(90, 203)];[(9, 32);(90, 204)]","['V89E', 'P90S', 'P91E'];['P90S', 'P91E'];['P90S', 'P91E'];['P90S', 'P91E']",";,attachment at N-terminal with length 2 have been removed from coverage;,;,"
5,BCL2,P10415,1,6O0P,2019-02-17,X-RAY DIFFRACTION,1.8,fusion product,"['BCL2_HUMAN, P10415, chain_A;B2CL1_HUMAN, Q07817, chain_A']",NA,NA,Other ligands,"4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-[(3-nitro-4-{[(oxan-4-yl)methyl]amino}phenyl)sulfonyl]-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide, chain A;DI(HYDROXYETHYL)ETHER, chain A",A,"[(9, 35);(90, 203)]","['V35D', 'P90S', 'P91E', 'G101A']",NA
6,BCL2,P10415,1,5VAY,2017-03-28,X-RAY DIFFRACTION,1.804,fusion product in protein complex,"['BECN1_HUMAN, Q14457, chain_E;BCL2_HUMAN, P10415, chain_A;B2CL1_HUMAN, Q07817, chain_A']",NA,NA,NA,NA,B;A;D;C,"[(4, 31);(89, 205)];[(1, 32);(90, 206)];[(10, 31);(90, 203)];[(9, 32);(90, 204)]","['V89E', 'P90S', 'P91E'];['P90S', 'P91E'];['P90S', 'P91E'];['P90S', 'P91E']",";,attachment at N-terminal with length 2 have been removed from coverage;,;,"
7,BCL2,P10415,1,4LXD,2013-07-29,X-RAY DIFFRACTION,1.9,NA,NA,NA,NA,Other ligands,"['4-(4-{[4-(4-chlorophenyl)-5,6-dihydro-2H-pyran-3-yl]methyl}piperazin-1-yl)-N-{[3-nitro-4-(tetrahydro-2H-pyran-4-ylamino)phenyl]sulfonyl}benzamide, chain A']",A,"[(90, 204)]","['P90S', 'P91E']",attachment at N-terminal with length 28 have been removed from coverage
8,BCL2,P10415,1,6O0O,2019-02-17,X-RAY DIFFRACTION,1.998,fusion product,"['BCL2_HUMAN, P10415, chain_A;B2CL1_HUMAN, Q07817, chain_A']",NA,NA,Other ligands,"['~{N}-(4-hydroxyphenyl)-3-[6-[[(3~{S})-3-(morpholin-4-ylmethyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]-1,3-benzodioxol-5-yl]-~{N}-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide, chain A,C']",C;A,"[(91, 203)];[(91, 203)]","['P91E', 'G101V'];['P91E', 'G101V']","attachment at N-terminal with length 23 have been removed from coverage;,attachment at N-terminal with length 24 have been removed from coverage"
9,BCL2,P10415,1,5VAX,2017-03-28,X-RAY DIFFRACTION,2,protein complex,"['BECN1_HUMAN, Q14457, chain_E;BCL2_HUMAN, P10415, chain_A']",NA,NA,NA,NA,B;A;D;C,"[(7, 31);(86, 207)];[(9, 31);(88, 207)];[(9, 32);(91, 204)];[(10, 31);(90, 203)]","['L86E', 'S87G', 'P88T', 'V89E', 'P90S', 'P91E'];['P88T', 'V89E', 'P90S', 'P91E'];['A32D', 'P91E'];['P90S', 'P91E']",NA
10,BCL2,P10415,1,4LVT,2013-07-26,X-RAY DIFFRACTION,2.05,NA,NA,NA,NA,Other ligands,"['4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-[(4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-[(trifluoromethyl)sulfonyl]phenyl)sulfonyl]benzamide, chain A,B']",B;A,"[(90, 204)];[(90, 204)]","['P90S', 'P91E'];['P90S', 'P91E']","attachment at N-terminal with length 24 have been removed from coverage;,attachment at N-terminal with length 24 have been removed from coverage"
11,BCL2,P10415,1,7LHB,2021-01-21,X-RAY DIFFRACTION,2.068,NA,NA,NA,NA,Other ligands,"['Phosphoric acid mono-[5-(5-{4-[2-(4-chloro-phenyl)-4,4-dimethyl-cyclohex-1-enylmethyl]-piperazin-1-yl}-2-{3-nitro-4-[(tetrahydro-pyran-4-ylmethyl)-amino]-benzenesulfonylaminocarbonyl}-phenoxy)-pyrrolo[2,3-b]pyridin-7-ylmethyl] ester, chain A,B,C']",B;A;C,"[(9, 30);(91, 204)];[(9, 30);(90, 204)];[(10, 30);(94, 202)]","['R26K', 'P91E'];['R26K', 'P90S', 'P91E'];['R26K']",NA
12,BCL2,P10415,1,4MAN,2013-08-16,X-RAY DIFFRACTION,2.07,NA,NA,NA,NA,Other ligands,"[""4-[4-({4'-chloro-3-[2-(dimethylamino)ethoxy]biphenyl-2-yl}methyl)piperazin-1-yl]-2-(1H-indol-5-yloxy)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)benzamide, chain A,B""]",B;A,"[(91, 204)];[(91, 204)]",['P91E'];['P91E'],"attachment at N-terminal with length 22 have been removed from coverage;,attachment at N-terminal with length 22 have been removed from coverage"
13,BCL2,P10415,1,5JSN,2016-05-09,X-RAY DIFFRACTION,2.1,NA,NA,NA,NA,NA,NA,C;A,"[(7, 32);(87, 209)];[(7, 32);(87, 209)]","['P208L', 'L209E'];['P208L', 'L209E']","The structure likely contains an expression tag,;The structure likely contains an expression tag,"
14,BCL2,P10415,1,5FCG,2015-12-15,X-RAY DIFFRACTION,2.1,protein complex,"['BCL2_HUMAN, P10415, chain_A;X_HBVF4, Q99HR6, chain_C']",NA,NA,NA,NA,A,"[(77, 79);(87, 203)]","['P78E', 'G79E', 'S87G', 'P88T', 'V89E', 'P90S', 'P91E', 'T96A', 'R129C']",attachment at N-terminal with length 30 have been removed from coverage
15,BCL2,P10415,1,4IEH,2012-12-13,X-RAY DIFFRACTION,2.1,fusion product,"['BCL2_HUMAN, P10415, chain_A;B2CL1_HUMAN, Q07817, chain_A']",NA,NA,Other ligands,"[""N-(6-{4-[(4'-chlorobiphenyl-2-yl)methyl]piperazin-1-yl}-1,1-dioxido-1,2-benzothiazol-3-yl)-4-{[(2R)-4-(dimethylamino)-1-(phenylsulfanyl)butan-2-yl]amino}-3-nitrobenzenesulfonamide, chain A""]",A,"[(90, 204)]","['P90S', 'P91E']",attachment at N-terminal with length 23 have been removed from coverage
16,BCL2,P10415,1,2W3L,2008-11-13,X-RAY DIFFRACTION,2.1,NA,NA,NA,NA,Other ligands,"['1-(2-{[(3S)-3-(aminomethyl)-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}phenyl)-4-chloro-5-methyl-N,N-diphenyl-1H-pyrazole-3-carboxamide, chain A,B']",B;A,"[(90, 204)];[(90, 206)]","['P90S', 'P91E', 'L95K', 'Q99E', 'Q118G'];['P90S', 'P91E', 'L95K', 'Q99E', 'Q118G']","attachment at N-terminal with length 27 have been removed from coverage;,attachment at N-terminal with length 24 have been removed from coverage"
17,BCL2,P10415,1,6O0L,2019-02-16,X-RAY DIFFRACTION,2.2,fusion product,"['BCL2_HUMAN, P10415, chain_A;B2CL1_HUMAN, Q07817, chain_A']",NA,NA,Other ligands,"4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-[(3-nitro-4-{[(oxan-4-yl)methyl]amino}phenyl)sulfonyl]-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide, chain A,C;DI(HYDROXYETHYL)ETHER, chain A,C;CHLORIDE ION, chain A,C",C;A,"[(8, 33);(90, 203)];[(9, 33);(90, 203)]","['P90S', 'P91E', 'G101V'];['P90S', 'P91E', 'G101V']",NA
18,BCL2,P10415,1,5AGX,2015-02-04,X-RAY DIFFRACTION,2.24,fusion product in protein complex,"['B2L11_HUMAN, O43521, chain_C;BCL2_HUMAN, P10415, chain_A;B2CL1_HUMAN, Q07817, chain_A']",NA,NA,NA,NA,B;A,"[(8, 32);(89, 204)];[(8, 32);(90, 204)]","['V89E', 'P90S', 'P91E', 'L175I'];['P90S', 'P91E']",NA
19,BCL2,P10415,1,4AQ3,2012-04-12,X-RAY DIFFRACTION,2.4,fusion product,"['BCL2_HUMAN, P10415, chain_A;B2CL1_HUMAN, Q07817, chain_A']",NA,NA,Other ligands,"['N,N-dibutyl-4-chloranyl-1-[2-(3,4-dihydro-1H-isoquinolin-2-ylcarbonyl)-4-[(7-iodanylnaphthalen-2-yl)sulfonylcarbamoyl]phenyl]-5-methyl-pyrazole-3-carboxamide, chain A,B,C,D,E,F']",A;B;C;F;E;D,"[(92, 203)];[(92, 203)];[(92, 203)];[(91, 203)];[(92, 203)];[(90, 203)]","['T96A', 'R110G'];['T96A', 'R110G'];['T96A', 'R110G'];['P91E', 'T96A', 'R110G'];['T96A', 'R110G'];['P90S', 'P91E', 'T96A', 'R110G']","attachment at N-terminal with length 23 have been removed from coverage;,attachment at N-terminal with length 23 have been removed from coverage;,attachment at N-terminal with length 23 have been removed from coverage;,attachment at N-terminal with length 24 have been removed from coverage;,attachment at N-terminal with length 23 have been removed from coverage;,attachment at N-terminal with length 23 have been removed from coverage"
20,BCL2,P10415,1,6IWB,2018-12-05,X-RAY DIFFRACTION,2.5,protein complex,"['BCL2_HUMAN, P10415, chain_B;APOE_HUMAN, P02649, chain_A']",NA,NA,Other ligands,"['SULFATE ION, chain A']",B;D,"[(90, 205)];[(90, 205)]","['P90S', 'P91E'];['P90S', 'P91E']","attachment at N-terminal with length 23 have been removed from coverage;,attachment at N-terminal with length 23 have been removed from coverage"
21,BCL2,P10415,1,5AGW,2015-02-04,X-RAY DIFFRACTION,2.695,fusion product in protein complex,"['B2L11_HUMAN, O43521, chain_C;BCL2_HUMAN, P10415, chain_A;B2CL1_HUMAN, Q07817, chain_A']",NA,NA,NA,NA,B;A,"[(10, 31);(90, 204)];[(8, 31);(90, 204)]","['P90S', 'P91E'];['P90S', 'P91E']",NA
22,BCL2,P10415,1,2XA0,2010-03-25,X-RAY DIFFRACTION,2.7,protein complex,"['BAX_MOUSE, Q07813, chain_C;BCL2_HUMAN, P10415, chain_A']",NA,NA,NA,NA,B;A,"[(10, 31);(92, 206)];[(10, 31);(92, 206)]",NA,NA
23,BCL2,P10415,1,2O21,2006-11-29,SOLUTION NMR,NA,NA,NA,NA,NA,Other ligands,"['3-NITRO-N-{4-[2-(2-PHENYLETHYL)-1,3-BENZOTHIAZOL-5-YL]BENZOYL}-4-{[2-(PHENYLSULFANYL)ETHYL]AMINO}BENZENESULFONAMIDE, chain A']",A,"[(47, 51);(92, 207)]","['I48T', 'F49E', 'S51E']",attachment at N-terminal with length 43 have been removed from coverage
24,BCL2,P10415,1,2O22,2006-11-29,SOLUTION NMR,NA,NA,NA,NA,NA,Other ligands,"['N-[(4-{[1,1-dimethyl-2-(phenylthio)ethyl]amino}-3-nitrophenyl)sulfonyl]-4-(4,4-dimethylpiperidin-1-yl)benzamide, chain A']",A,"[(47, 51);(92, 207)]","['I48T', 'F49E', 'S51E']",attachment at N-terminal with length 43 have been removed from coverage
25,BCL2,P10415,1,2O2F,2006-11-29,SOLUTION NMR,NA,NA,NA,NA,NA,Other ligands,"['4-(4-BENZYL-4-METHOXYPIPERIDIN-1-YL)-N-[(4-{[1,1-DIMETHYL-2-(PHENYLTHIO)ETHYL]AMINO}-3-NITROPHENYL)SULFONYL]BENZAMIDE, chain A']",A,"[(51, 51);(92, 204)]",['S51E'],attachment at N-terminal with length 24 have been removed from coverage
26,BCL2,P10415,1,1YSW,2005-02-09,SOLUTION NMR,NA,NA,NA,NA,NA,Other ligands,"['3-NITRO-N-{4-[2-(2-PHENYLETHYL)-1,3-BENZOTHIAZOL-5-YL]BENZOYL}-4-{[2-(PHENYLSULFANYL)ETHYL]AMINO}BENZENESULFONAMIDE, chain A']",A,"[(47, 51);(92, 207)]","['I48T', 'F49E', 'S51E']",attachment at N-terminal with length 43 have been removed from coverage
27,BCL2,P10415,1,1GJH,2001-05-31,SOLUTION NMR,NA,NA,NA,NA,NA,NA,NA,A,"[(3, 50);(92, 207)]","['V35D', 'G36V', 'A37E', 'A38E', 'P39N', 'P40R', 'G41T', 'A42E', 'A45E', 'P46G', 'G47T', 'I48E', 'F49S', 'S50E']",NA
28,BCL2,P10415,1,1G5M,2000-11-01,SOLUTION NMR,NA,NA,NA,NA,NA,NA,NA,A,"[(3, 50);(92, 207)]","['V35D', 'G36V', 'A37E', 'A38E', 'P39N', 'P40R', 'G41T', 'A42E', 'A45E', 'P46G', 'G47T', 'I48E', 'F49S', 'S50E', 'T96A', 'R110G']",NA
